ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BCRX BioCryst Pharmaceuticals Inc

6.26
-0.18 (-2.80%)
08 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 65.53M75.83M79.55M68.78M82.49M86.74M93.4M92.76M
Operating Income -34.72M-17.45M-46.31M-28.42M-20.7M-19.26M-42.67M-14.49M
Pre Tax Income -58M-41M-71.47M-52.66M-74.59M-35.82M-63.16M-35.01M
Net Income -58.86M-42.52M-71.54M-53.33M-75.33M-36.15M-61.73M-35.38M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -34.72M-17.45M-46.31M-28.42M-20.7M-19.26M-42.67M-14.49M
EBITDA -34.39M-17.06M-45.92M-28.01M-20.3M-18.84M-40.7M-14.18M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 26.35M25.19M20.65M48.84M17.81M157.17M270.83M331.41M
Operating Income -48.61M-57.41M-94.22M-99.46M-174.76M-177.72M-148.44M-103.71M
Pre Tax Income -55.14M-65.78M-101.25M-108.9M-182.81M-181.81M-244.38M-226.23M
Net Income -55.14M-65.78M-101.25M-108.9M-182.81M-184.06M-247.12M-226.54M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.747-0.668-0.92-0.707-1.034-0.998-1.315-1.106
EBIT -48.61M-57.41M-94.22M-99.46M-176.77M-177.72M-148.44M-103.71M
EBITDA -48.12M-56.71M-93.45M-98.73M-174.01M-176.94M-147M-100.51M